Table 2 Characteristics of the study population and the tumors on inclusion. Data are quoted as the number (percentage) or the median (range).

From: Correlation between toxicity and dosimetric parameters for adjuvant intensity modulated radiation therapy of breast cancer: a prospective study

Demographic and health characteristics (n = 288)

Age, years

55 (32–82)

Past or current smokers

79 (27.4%)

Number of packets per year (n = 72)

17.5 (0.5–51)

Duration (years)

28 (2–47)

Current and/or past health conditions

History of heart disease

94 (23.8%)

Current diabetes

43 (14.9%)

Current dyslipidemia

91 (28.3%)

History of respiratory disease

29 (10.1%)

Family history of breast cancer

122 (42.4%)

BMI (kg/m2)

26.5 (16.5–48.8)

Normal weight

111 (38.8%)

Overweight (BMI ≥ 25)

95 (33.2%)

Obesity(BMI ≥ 30)

80 (28%)

WHO score

0

222 (79%)

1

58 (20.6%)

2

1 (0.4%)

Breast size

Small (85A-B, 90A)

31 (11.6%)

Medium (85C, 90B-C, 95A-B)

76 (28.4%)

Large (> 85C, > 90C, > 95B)

161 (60.1%)

Tumor characteristics (n = 288)

Tumor side

Right

130 (45.1%)

Left

142 (49.3%)

Bilateral

16 (5.6%)

Histology

Invasive ductal carcinoma

217 (75.4%)

Invasive lobular carcinoma

33 (11.4%)

Other

38 (13.2%)

In situ component (n = 281)

116 (41.3%)

SBR grade

SBR I

64 (24.2%)

SBR II

143 (54.2%)

SBR III

57 (21.6%)

ER + (n = 286)

243 (85.0%)

PR + (n = 286)

205 (71.7%)

HER2 + (n = 273)

42 (15.4%)

Triple-negative (n = 288)

28 (9.7%)

pT grade (n = 265)

pT1

122 (46%)

pT2

110 (41.5%)

pT3

30 (11.3%)

pT4

3 (1.1%)

pN grade (n = 275)

pN0

60 (21.8%)

pN1

158 (57.5%)

pN2

42 (15.3%)

pN3

15 (5.5%)

  1. WHO World Health Organization, BMI body mass index, SBR Scarff-Bloom and Richardson.